Unknown

Dataset Information

0

Web-Based Skin Cancer Assessment and Classification Using Machine Learning and Mobile Computerized Adaptive Testing in a Rasch Model: Development Study.


ABSTRACT:

Background

Web-based computerized adaptive testing (CAT) implementation of the skin cancer (SC) risk scale could substantially reduce participant burden without compromising measurement precision. However, the CAT of SC classification has not been reported in academics thus far.

Objective

We aim to build a CAT-based model using machine learning to develop an app for automatic classification of SC to help patients assess the risk at an early stage.

Methods

We extracted data from a population-based Australian cohort study of SC risk (N=43,794) using the Rasch simulation scheme. All 30 feature items were calibrated using the Rasch partial credit model. A total of 1000 cases following a normal distribution (mean 0, SD 1) based on the item and threshold difficulties were simulated using three techniques of machine learning-naïve Bayes, k-nearest neighbors, and logistic regression-to compare the model accuracy in training and testing data sets with a proportion of 70:30, where the former was used to predict the latter. We calculated the sensitivity, specificity, receiver operating characteristic curve (area under the curve [AUC]), and CIs along with the accuracy and precision across the proposed models for comparison. An app that classifies the SC risk of the respondent was developed.

Results

We observed that the 30-item k-nearest neighbors model yielded higher AUC values of 99% and 91% for the 700 training and 300 testing cases, respectively, than its 2 counterparts using the hold-out validation but had lower AUC values of 85% (95% CI 83%-87%) in the k-fold cross-validation and that an app that predicts SC classification for patients was successfully developed and demonstrated in this study.

Conclusions

The 30-item SC prediction model, combined with the Rasch web-based CAT, is recommended for classifying SC in patients. An app we developed to help patients self-assess SC risk at an early stage is required for application in the future.

SUBMITTER: Yang TY 

PROVIDER: S-EPMC9282670 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7657939 | biostudies-literature
| S-EPMC11342194 | biostudies-literature
| S-EPMC4795329 | biostudies-literature
| S-EPMC6572910 | biostudies-literature
| S-EPMC10572538 | biostudies-literature
| S-EPMC9197499 | biostudies-literature
| S-EPMC8237239 | biostudies-literature
| S-EPMC7433381 | biostudies-literature
| S-EPMC5968224 | biostudies-literature
| S-EPMC7270851 | biostudies-literature